Suppr超能文献

滤泡状癌肝转移灶功能亢进导致的严重甲状腺毒症:采用碘-131和间质激光消融治疗

Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: treatment with (131)I and interstitial laser ablation.

作者信息

Guglielmi R, Pacella C M, Dottorini M E, Bizzarri G C, Todino V, Crescenzi A, Rinaldi R, Panunzi C, Rossi Z, Colombo L, Papini E

机构信息

Department of Endocrine, Metabolic and Digestive Diseases, Ospedale Regina Apostolorum, Albano, Rome, Italy.

出版信息

Thyroid. 1999 Feb;9(2):173-7. doi: 10.1089/thy.1999.9.173.

Abstract

Liver metastases from differentiated thyroid tumors are unusual clinical findings, and are only rarely hyperfunctioning. We report a case of thyrotoxicosis caused by a huge and surgically unresectable liver metastasis from follicular thyroid cancer, unresponsive to treatment with large doses of thionamides. To avoid the hazardous side effects of (131)I treatment in a severely thyrotoxic patient, a preliminary debulking of the liver mass was performed by means of percutaneous interstitial laser photocoagulation. Three treatments (total energy delivery: 7200 J) were performed under ultrasound guidance, with no serious complications, during a 2-week period. One month later, serum thyroid hormones had decreased, general condition was improved, and magnetic resonance evaluation revealed large and well-defined areas of necrosis of metastatic tissue. During the following 10 months, the patient underwent 3 radioiodine treatments. Eighteen months after diagnosis, thyroid hormones were within normal levels, liver mass decreased, and the clinical condition markedly improved. The combination of percutaneous interstitial laser photocoagulation treatment and radioiodine therapy made possible the effective management of a hyperfunctioning and surgically untreatable liver metastasis from thyroid follicular carcinoma, avoiding the side effects of (131)I therapy in a thyrotoxic patient and increasing the effectiveness of radioiodine-induced neoplastic tissue ablation.

摘要

分化型甲状腺肿瘤的肝转移是不常见的临床发现,且极少出现功能亢进。我们报告一例由巨大且手术无法切除的甲状腺滤泡癌肝转移导致的甲状腺毒症病例,该病例对大剂量硫代酰胺治疗无反应。为避免在严重甲状腺毒症患者中进行(131)I治疗的有害副作用,通过经皮间质激光光凝对肝脏肿块进行了初步减瘤。在超声引导下进行了三次治疗(总能量传递:7200焦耳),在两周内未出现严重并发症。一个月后,血清甲状腺激素下降,一般状况改善,磁共振评估显示转移组织有大片界限清晰的坏死区域。在接下来的10个月里,患者接受了3次放射性碘治疗。诊断后18个月,甲状腺激素水平恢复正常,肝脏肿块缩小,临床状况明显改善。经皮间质激光光凝治疗与放射性碘治疗相结合,使得有效处理甲状腺滤泡癌功能亢进且手术无法治疗的肝转移成为可能,避免了甲状腺毒症患者接受(131)I治疗的副作用,并提高了放射性碘诱导的肿瘤组织消融的有效性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验